ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

During the Trading Day
11.78 +1.28 / +12.19%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
11.35 -0.43 / -3.65%
 
Volume: 206.3K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.2B

Company Description

ZIOPHARM Oncology, Inc. is a biopharmaceutical company currently in developmental stage that seeks to acquire, develop and commercialize, on its own or with commercial partners, a diverse portfolio of cancer therapies. The company also has a portfolio of small molecule drug candidates, which are no longer a strategic focus of its development activities for which the company is seeking partners to pursue further development and commercialization. It is currently focused on two clinical stage product candidates: Ad-RTS-IL-12 + veledimex and DC-RTS-IL-12 + veledimex. Ziopharm Oncology was founded on September 9, 2003 and is headquartered in Boston, MA.

Contact Information

ZIOPHARM Oncology, Inc.
1180 Avenue of the Americas
New York Massachusetts 10036
P:(646) 214-0700
Investor Relations:

Employees

Shareholders

Individual stakeholders32.25%
Other institutional14.69%
Mutual fund holders10.16%

Top Executives

There are no executives to display.

To view my watchlist

Not a member yet?

Sign up now for a free account